This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
National Vision (EYE) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
National Vision (EYE) delivered earnings and revenue surprises of +38.46% and +3.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Colgate Tops Q2 Earnings & Sales Estimates, Tweaks Organic Sales View
by Zacks Equity Research
CL beats Q2 earnings and sales estimates on pricing and organic growth but narrows the full-year organic sales view to the low end of the 2-4% range.
Are Consumer Staples Stocks Lagging National Vision (EYE) This Year?
by Zacks Equity Research
Here is how National Vision (EYE) and Nestle SA (NSRGY) have performed compared to their sector so far this year.
National Vision Holdings, Inc. (EYE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
National Vision (EYE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is National Vision (EYE) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how National Vision (EYE) and Nestle SA (NSRGY) have performed compared to their sector so far this year.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is This the Right Time to Hold EYE Stock in Your Portfolio?
by Zacks Equity Research
National Vision gains from America's Best momentum and strategic revamp, but solvency issues and rising costs weigh on profitability.
Why Is National Vision (EYE) Up 25.1% Since Last Earnings Report?
by Zacks Equity Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why National Vision (EYE) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why National Vision (EYE) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
EYE Q1 Earnings and Revenues Beat, Gross Margin Up, Stock Surges
by Zacks Equity Research
Continued strength in Managed Care aids National Vision's first-quarter 2025 performance.
National Vision (EYE) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
National Vision (EYE) delivered earnings and revenue surprises of 17.24% and 1.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Coca-Cola Europacific Partners (CCEP) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Coca-Cola European (CCEP) and National Vision (EYE) have performed compared to their sector so far this year.
National Vision (EYE) Soars 9.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
National Vision (EYE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Is it the Right Time to Add EYE Stock to Your Portfolio Now?
by Zacks Equity Research
National Vision continues to draw investors' attention with its strategic transformation efforts. Positive industry trends should also favor its growth.
New Strong Buy Stocks for April 9th
by Zacks Equity Research
PRAA, SAN, EYE, WTKWY and NWSA have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2025.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
National Vision (EYE) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
National Vision (EYE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's Why National Vision (EYE) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fast-paced Momentum Stock National Vision (EYE) Is Still Trading at a Bargain
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, National Vision (EYE) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
National Vision (EYE) Up 7.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
National Vision Stock Rises 28.2% YTD: Will the Rally Continue?
by Zacks Equity Research
EYE's strength in its largest brand and actions to achieve a healthier store fleet position the stock favorably.
Is National Vision (EYE) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how National Vision (EYE) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
EYE or CL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
EYE vs. CL: Which Stock Is the Better Value Option?
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.